SS Innovations International (NASDAQ:SSII) Posts Quarterly Earnings Results

SS Innovations International (NASDAQ:SSII) issued its earnings results on Tuesday. The company reported $0.04 earnings per share for the quarter, FiscalAI reports. SS Innovations International had a negative return on equity of 34.13% and a negative net margin of 32.10%.

SS Innovations International Price Performance

SS Innovations International stock opened at $5.53 on Thursday. SS Innovations International has a 12-month low of $3.02 and a 12-month high of $22.42. The company has a market capitalization of $1.07 billion and a price-to-earnings ratio of -110.60. The firm’s fifty day moving average price is $5.99 and its 200 day moving average price is $6.57.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of SS Innovations International in a research report on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, SS Innovations International currently has a consensus rating of “Sell”.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the business. Handelsbanken Fonder AB acquired a new stake in shares of SS Innovations International during the third quarter worth approximately $714,000. PNC Financial Services Group Inc. acquired a new position in shares of SS Innovations International during the third quarter worth approximately $56,000. Envestnet Asset Management Inc. acquired a new stake in SS Innovations International in the third quarter worth about $71,000. Inspire Investing LLC bought a new position in shares of SS Innovations International in the third quarter valued at approximately $240,000. Finally, Geode Capital Management LLC acquired a new position in shares of SS Innovations International during the 2nd quarter valued at $122,000.

SS Innovations International Company Profile

AVRA Medical Robotics, Inc develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc and changed its name to AVRA Medical Robotics, Inc in November 2015. AVRA Medical Robotics, Inc was founded in 2015 and is based in Orlando, Florida.